The MEG Regeneration and Reclaiming Technology developed by CCR Technologies Ltd. is a pioneer technology with the first commercial operation in the world of a MEG reclaiming unit being started-up in 1999 for Shell Mensa Offshore Project in the Gulf of Mexico.
An orexigenic, or appetite stimulant, is a drug, hormone, or compound that increases appetite.n orexigenic, or appetite stimulant, is a drug, hormone, or compound that increases appetite.
Kidney, liver and heart disease can also reduce the appetite. In some cases, sudden loss of appetite occurs at an advanced stage illness, such as congestive heart failure or kidney failure. Psychological diseases including depression, anxiety disorder and schizophrenia can also cause sudden loss of appetite, particularly if symptoms of the underlying disease increase suddenly.